Comparative Study of the Effects of Isatin, an Endogenous MAO-Inhibitor, and Selegiline on Bradykinesia and Dopamine Levels in a Rat Model of Parkinson's Disease Induced by the Japanese Encephalitis Virus

Author： Hamaue N.   Minami M.   Terado M.   Hirafuji M.   Endo T.   Machida M.   Hiroshige T.   Ogata A.   Tashiro K.   Saito H.   Parvez S.H.  

Publisher： Elsevier

ISSN： 0161-813X

Source： Neurotoxicology, Vol.25, Iss.1, 2004-01, pp. : 205-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease

By Tábi Tamás   Szökő Éva   Vécsei László   Magyar Kálmán  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 629-636

Informa Healthcare

Access to resources Recommend Favorite

Safety of Selegiline (Deprenyl) in the Treatment of Parkinson's Disease

By Heinonen E.H.  

Drug Safety, Vol. 19, Iss. 1, 1998-07 ,pp. : 11-22

Adis International

Access to resources Recommend Favorite

Orally disintegrating selegiline for the treatment of Parkinson's disease

By Löhle Matthias   Storch Alexander  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2881-2891

Informa Healthcare

Access to resources Recommend Favorite

Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens

By Ichikawa J.   Kuroki T.   Meltzer H.Y.  

European Journal of Pharmacology, Vol. 350, Iss. 2, 1998-06 ,pp. : 159-164

Elsevier

Access to resources Recommend Favorite

Fentanyl: Bradykinesia and rigidity in a patient with Parkinson's disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite